Eli Lilly to launch four mega drugs in 2 years
Eli Lilly & Company is hoping to increase its product portfolio in India with the launch of at least four new blockbuster drugs in two years. These drugs are Alimta for mesothelioma, PKC inhibitors
Eli Lilly & Company is hoping to increase its product portfolio in India with the launch of at least four new blockbuster drugs in two years. These drugs are Alimta for mesothelioma, PKC inhibitors